Stereotaxis Inc. (STXS) announced after the close Monday that it was granted 510(k) clearance by the FDA to market its Vdrive Robotic Navigation System with V-Sono(TM) Intracardiac Echocardiography catheter manipulator.
Stereotaxis gapped up Tuesday and has continued to rise on strong volume. The stock is currently higher by 3.77 at $5.55 and has surged to a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News